Mojca Božič Mijovski

1.0k total citations
70 papers, 713 citations indexed

About

Mojca Božič Mijovski is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Mojca Božič Mijovski has authored 70 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cardiology and Cardiovascular Medicine, 22 papers in Internal Medicine and 21 papers in Surgery. Recurrent topics in Mojca Božič Mijovski's work include Venous Thromboembolism Diagnosis and Management (22 papers), Blood Coagulation and Thrombosis Mechanisms (13 papers) and Atrial Fibrillation Management and Outcomes (11 papers). Mojca Božič Mijovski is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (22 papers), Blood Coagulation and Thrombosis Mechanisms (13 papers) and Atrial Fibrillation Management and Outcomes (11 papers). Mojca Božič Mijovski collaborates with scholars based in Slovenia, Sweden and Italy. Mojca Božič Mijovski's co-authors include Mojca Stegnar, Aleš Blinc, Nina Vene, Polona Peternel, Alenka Mavri, Jovan P. Antović, Borut Jug, Rickard E. Malmström, Pavel Poredoš and Anton Pohanka and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and European Heart Journal.

In The Last Decade

Mojca Božič Mijovski

66 papers receiving 698 citations

Peers

Countries citing papers authored by Mojca Božič Mijovski

Since Specialization

Citations

This map shows the geographic impact of Mojca Božič Mijovski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mojca Božič Mijovski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mojca Božič Mijovski more than expected).

Fields of papers citing papers by Mojca Božič Mijovski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mojca Božič Mijovski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mojca Božič Mijovski. The network helps show where Mojca Božič Mijovski may publish in the future.

Co-authorship network of co-authors of Mojca Božič Mijovski

This figure shows the co-authorship network connecting the top 25 collaborators of Mojca Božič Mijovski. A scholar is included among the top collaborators of Mojca Božič Mijovski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mojca Božič Mijovski. Mojca Božič Mijovski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Multicenter Evaluation of Different Anti-Xa Assays and Diluted Russell’s Viper Venom Time in Ex Vivo Plasma Samples from Patients Treated with Rivaroxaban or Apixaban 2025 ·Journal of Clinical Medicine ·Mojca Božič Mijovski, Alenka Mavri, Jovan P. Antović, Rickard E. Malmström, Désirée Coen Herak	0
2	Residual non-specific and disease-specific inflammatory markers in successfully treated young psoriasis patients: a cross-sectional study 2025 ·Immunologic Research ·(unknown), (unknown), Mojca Božič Mijovski, Miodrag Janić	2
3	Clot time ratio (CTR) and treatment outcomes in Apixaban-treated atrial fibrillation patients 2024 ·Scientific Reports ·Liselotte Onelöv, Mojca Božič Mijovski, Alenka Mavri	1
4	Relation of JAK2 V617F allele burden and coronary calcium score in patients with essential thrombocythemia 2024 ·Radiology and Oncology ·(unknown), Aleš Blinc, Mojca Božič Mijovski, (unknown), (unknown), Matjaž Sever	1
5	Arterial function is preserved in successfully treated patients with psoriasis vulgaris 2024 ·Science Progress ·(unknown), (unknown), Mojca Božič Mijovski, Miodrag Janić	2
6	Prognostic Factors for Restenosis of Superficial Femoral Artery after Endovascular Treatment 2023 ·Journal of Clinical Medicine ·Vinko Boc, Matija Kozak, (unknown), Mojca Božič Mijovski, (unknown), Aleš Blinc	2
7	Insulin resistance, lipids and body composition in patients with coronary artery disease after combined aerobic training and resistance training: a randomised, controlled trial 2023 ·Diabetology & Metabolic Syndrome ·(unknown), Mojca Božič Mijovski, Borut Jug, Vedran Hadžić, Mitja Lainščak	4
8	Cangrelor for comatose survivors of out-of-hospital cardiac arrest undergoing percutaneous coronary intervention: the CANGRELOR-OHCA study. 2023 ·PubMed ·Peter Kordis, Mojca Božič Mijovski, (unknown), Klemen Steblovnik, Aleš Blinc, Marko Noč	11
9	Assessment of short-term effect of platelet-rich plasma treatment of tendinosis using texture analysis of ultrasound images 2023 ·Radiology and Oncology ·(unknown), Vladka Salapura, Žiga Snoj, (unknown), Mojca Božič Mijovski, (unknown)	2
10	Idarucizumab for dabigatran reversal in daily clinical practice 2020 ·European Journal of Anaesthesiology ·Nina Vene, Alenka Mavri, Mojca Božič Mijovski, (unknown), (unknown), (unknown), Primož Gradišek, Adela Stecher, Senta Frol, (unknown), (unknown), (unknown)	8
11	Progression of coronary calcium burden and carotid stiffness in patients with essential thrombocythemia associated with JAK2 V617F mutation 2020 ·Atherosclerosis ·(unknown), (unknown), Mojca Božič Mijovski, Matjaž Sever, Irena Preložnik Zupan, Nataša Kejžar, Aleš Blinc	13
12	Short-Term Water- and Land-Based Exercise Training Comparably Improve Exercise Capacity and Vascular Function in Patients After a Recent Coronary Event: A Pilot Randomized Controlled Trial 2019 ·Frontiers in Physiology ·(unknown), M Novakovic, Mojca Božič Mijovski, (unknown), Borut Jug	18
13	Survival and event-free survival of patients with peripheral arterial disease undergoing prevention of cardiovascular disease 2017 ·International Angiology ·Aleš Blinc, Matija Kozak, Mišo Šabović, Mojca Božič Mijovski, Mojca Stegnar, Pavel Poredoš, (unknown), (unknown), Janez Stare, Maja Pohar Perme	14
14	Increased Plasma Cathepsin S at the Time of Percutaneous Transluminal Angioplasty is Associated with 6-Months’ Restenosis of the Femoropopliteal Artery 2017 ·Journal of Medical Biochemistry ·Mojca Božič Mijovski, Vinko Boc, Urša Pečar Fonović, Janja Marc, Aleš Blinc, Janko Kos, Darko Černe	2
15	Nurr1 Haplotypes are Associated with Femoropopliteal Restenosis/Re-occlusion after Percutaneous Transluminal Angioplasty 2012 ·European Journal of Vascular and Endovascular Surgery ·Mojca Božič Mijovski, (unknown), Mojca Stegnar, Vladka Salapura, Mateja K. Ježovnik, Matija Kozak, Aleš Blinc	7
16	Major and Potential Prothrombotic Genotypes in Patients with Venous Thrombosis and in Healthy Subjects from Slovenia 2007 ·Pathophysiology of Haemostasis and Thrombosis ·(unknown), Mojca Božič Mijovski, Polona Peternel, Mojca Stegnar	19
17	Utility of PFA-100® closure time vs. optical aggregometry in assessing the efficacy of platelet membrane glycoprotein IIb/IIIa antagonists in vitro 2007 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Mojca Stegnar, Mojca Božič Mijovski, Marija Sollner Dolenc, Marko Anderluh, D. Kikelj	4
18	Antithrombotic potential of new direct thrombin inhibitors built on the azaphenylalanine scaffold in two rat venous thrombosis models 2005 ·Thrombosis and Haemostasis ·Mojca Stegnar, Gorazd Drevenšek, (unknown), Mojca Božič Mijovski, Anamarija Zega, (unknown), (unknown), U. Urleb, Luka Peternel	5
19	Methyl-methacrylate bone cement surface does not promote platelet aggregation or plasma coagulation in vitro 2004 ·Thrombosis Research ·Aleš Blinc, Mojca Božič Mijovski, Rok Vengust, Mojca Stegnar	30
20	D-dimer, other markers of haemostasis activation and soluble adhesion molecules in patients with different clinical probabilities of deep vein thrombosis 2002 ·Thrombosis Research ·Mojca Božič Mijovski, Aleš Blinc, Mojca Stegnar	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact